The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2009, 182, 5763 -5769
Copyright © 2009 by The American Association of Immunologists, Inc.
doi:10.4049/jimmunol.0900124

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Related articles in The JI
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maitra, U.
Right arrow Articles by Li, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maitra, U.
Right arrow Articles by Li, L.

Differential Regulation of Foxp3 and IL-17 Expression in CD4 T Helper Cells by IRAK-11

Urmila Maitra*, Sarah Davis*, Christopher M. Reilly{dagger} and Liwu Li2,*

* Laboratory of Innate Immunity and Inflammation, Department of Biology, Virginia Polytechnic Institute and State University and {dagger} Virginia College of Osteopathic Medicine, Blacksburg, VA 24061

Host immune responses are finely regulated by the opposing effects of Th17 and T regulatory (Treg) cells. Treg cells help to dampen inflammatory processes and Th17 cells facilitate various aspects of immune activation. The differentiation of Th cells depends on a unique combination of stimulants and subsequent activation of diverse transcription factors. In particular, cooperative activation of NFAT and Smad3 leads to the induction of Treg cells, and cooperation among STAT3 and Smad3 switches to the induction of Th17 cells. We have previously shown that the IL-1 receptor associated kinase 1 (IRAK-1) selectively activates STAT3 and inactivates NFAT. Physiological studies have shown that IRAK-1–/– mice are protected from developing various inflammatory diseases, including experimental autoimmune encephalomyelitis and atherosclerosis with unknown mechanism. In this study, we demonstrate that IRAK-1 plays a critical modulatory role in the differentiation of Th17 and Treg cells. Following stimulation with TCR agonists and TGFβ, IRAK-1–/– CD4 Th cells display elevated nuclear NFATc2 levels and increased interaction of NFATc2 and Smad3, resulting in increased expression of Foxp3, a key marker for Treg cells. IRAK-1–/– mice have constitutively higher populations of Treg cells. In contrast, when stimulated with TCR agonists together with IL-6 and TGF-β, IRAK-1–/– CD4 Th cells exhibit attenuated STAT3 Ser727 phosphorylation and reduced expression of IL-17 and ROR{gamma}t compared with wild-type cells. Correspondingly, IRAK-1 deletion results in decreased IL-17 expression and dampened inflammatory responses in acute and chronic inflammatory mice models. Our data provides mechanistic explanation for the anti-inflammatory phenotypes of IRAK-1–/– mice.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by a research grant from the National Institutes of Health AI064414 (to L.L.).

2 Address correspondence to: Liwu Li, Life Science 1 Building, Washington Street, Department of Biology, Virginia Polytechnic Institute and State University, Blacksburg, VA 24061. E-mail address: lwli{at}vt.edu

3 Abbreviations used in this paper: Treg cells, T regulatory cells; ChIP, chromatin immunoprecipitation; EAE, experimental autoimmune encephalomyelitis; IRAK-1, interleukin-1 receptor associated kinase 1; PKC, protein kinase C; ROR{gamma}t, retinoic acid-related orphan receptor {gamma}t.


Related articles in The JI:

IN THIS ISSUE

The JI 2009 182: 5157-5158. [Full Text]  






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.